This potentially marks the first step toward mitigating a disease that has affected more than 150 million birds in the United ...
Center for Veterinary Biologics (CVB) issued Zoetis Inc (NYSE:ZTS) a conditional license for its Avian Influenza Vaccine, ...
Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting ...
The US Department of Agriculture last week issued a conditional license for an avian flu vaccine for use in chickens, as an ...
Spearheaded by National Economic Council Director Kevin Hassett and USDA Secretary Brooke Rollins, the plan prioritizes ...
PARSIPPANY, N.J., February 14, 2025--(BUSINESS WIRE)--Zoetis today announced that the U.S. Department of Agriculture (USDA), ...
A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An ...
Zoetis CEO Kristin Peck joins 'Closing Bell Overtime' to talk its Avian Flu vaccine, the impact of tariffs, and more.
Zoetis, the manufacturer behind the vaccine, announced the conditional approval Friday, saying in a news release its scientists had begun updating its existing avian flu vaccine in 2022.
Zoetis secured a USDA conditional license for its H5N2 avian flu vaccine for chickens, based on safety, purity, and serology-backed efficacy Over 150 million U.S. birds have been affected by ...